Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JSBiosciences is a leading global supplier of serum-free cell culture media with strong R&D capabilities. Its products are widely used in the development and manufacturing of antibody drugs, cell therapies, vaccines, and other biopharmaceuticals. The company supports over 100 clinical projects worldwide—including more than 20 at Phase III—by providing high-quality dry powder media produced at cGMP-compliant facilities across China, Singapore, and the US. It has established strategic partnerships to enable advanced protein expression platforms for biopharma customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JSBiosciences.